[1]郝明辉 郭明 唐宇 杨婧 柳子静 闫蕊 李萍 郭金成.急性ST段抬高型心肌梗死患者PCI后血清EREG水平及其与预后的关系[J].心血管病学进展,2020,(1):102-106.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.027]
 HAO Minghui,GUO Ming,TANG Yu,et al.Serum EREG Level after PCI and Its Relationship with Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(1):102-106.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.027]
点击复制

急性ST段抬高型心肌梗死患者PCI后血清EREG水平及其与预后的关系()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年1期
页码:
102-106
栏目:
论著
出版日期:
2020-02-04

文章信息/Info

Title:
Serum EREG Level after PCI and Its Relationship with Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction
作者:
郝明辉 郭明 唐宇 杨婧 柳子静 闫蕊 李萍 郭金成
(首都医科大学附属北京潞河医院心内科,北京 101100)
Author(s):
HAO Minghui GUO Ming TANG Yu YANG Jing LIU Zijing YAN Rui LI Ping GUO Jincheng
(Department of Cardiology, Beijing Luhe Hospital, Capital Medical University, Beijing 101100, China)
关键词:
急性ST段抬高型心肌梗死表皮调节素预后主要不良心血管事件
Keywords:
Acute ST-segment elevation myocardial infarction Epiregulin Prognosis Major adverse cardiovascular events
DOI:
10.16806/j.cnki.issn.1004-3934.2020.01.027
摘要:
目的 探究急性ST段抬高型心肌梗死(STEMI)患者经皮冠脉介入术后血清表皮调节素(epiregulin,EREG)水平及其与预后的关系。方法 前瞻性选取2017年6月—2018年4月接受救治的182例STEMI患者作为研究对象。根据STEMI患者预后情况将其分为预后良好组(n=157)和预后不良组(n=25)。采用双抗体夹心酶联免疫吸附法检测STEMI患者血清EREG水平,并分析其与预后的关系。结果 预后不良组血清EREG水平高于预后良好组,差异有统计学意义(P<0.05)。血清EREG评估STEMI患者1年预后的ROC曲线下面积、敏感度和特异度为0.931、100.00%和84.71%。EREG高水平组平均生存时间低于EREG低水平组,差异有统计学意义(P<0.05)。Cox单因素和多因素分析结果显示年龄、舒张压、低密度脂蛋白胆固醇和EREG与STEMI患者预后关系密切。结论 STEMI患者血清EREG水平与预后关系密切,血清EREG水平较高提示其预后不良。
Abstract:
Objective To investigate the relationship between serum epiregulin (EREG) levels after percutaneous coronary intervention and prognosis in patients with (STEMI). Methods A total of 182 patients with STEMI who underwent treatment from June 2017 to April 2018 were prospectively selected. According to the prognosis of patients with STEMI, they were divided into a good prognosis group (n=157) and a poor prognosis group (n=25). The serum EREG level of STEMI patients was detected by double antibody sandwich enzyme-linked immunosorbent assay, and its relationship with prognosis was analyzed. Results Serum EREG levels in the poor prognosis group were higher than those in the good prognosis group, and the difference was statistically significant (P<0.05).The ROC area under curve, sensitivity and specificity of serum EREG in evaluating one-year prognosis of STEMI patients were 0.931, 100.00% and 84.71%, respectively. The mean survival time of the EREG high-level group was lower than that of the EREG low-level group, and the difference was statistically significant (P<0.05). Cox univariate and multivariate analysis showed that age, diastolic blood pressure, low-density lipoprotein cholesterol and EREG were closely related to the prognosis of patients with STEMI. Conclusion Serum EREG levels in patients with STEMI are closely related to prognosis. Higher serum EREG levels suggest a poor prognosis.

参考文献/References:

[1].Liu J,Sun G,He Y,et al. Early β-blockers administration might be associated with a reduced risk of contrast-induced acute kidney injury in patients with acute myocardial infarction[J].J Thorac Dis,2019,11(4):1589-1596.
[2].张耘博,赵汉军.急性心肌梗死左心室附壁血栓的临床特征及治疗进展[J].心血管病学进展,2019,40(2):152-156.
[3].吴彩凤,徐日新,王大新. 微循环阻力指数在STEMI患者中的临床应用及进展[J].心血管病学进展,2018,39(6):944-947.
[4].Takahashi M,Hayashi K,Yoshida K,et al. Epiregulin as a major autocrine/paracrine factor released from ERK- and p38MAPK-activated vascular smooth muscle cells[J]. Circulation, 2003,108(20):2524-2529.
[5].中国医师协会急诊医师分会,中华医学会心血管病学分会,中华医学会检验医学分会.急性冠脉综合征急诊快速诊疗指南[J].中华急诊医学杂志,2016,25(4):397-404.
[6].Baker WL,Beyer-Westendorf J,Bunz TJ,et al. Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non-valvular atrial fibrillation and type 2 diabetes[J]. Diabetes Obes Metab, 2019,21(9):2107-2114.
[7].Reichlin T,Cullen L,Parsonage WA,et al. Two-hour algorithm for triage toward rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T[J]. Am J Med, 2015,128(4):369-379.e4.
[8].Niccoli G,Scalone G,Lerman A,et al. Coronary microvascular obstruction in acute myocardial infarction[J]. Eur Heart J,2016,37(13):1024-1033.
[9].Cai Y,Xie KL,Wu HL,et al. Functional suppression of Epiregulin impairs angiogenesis and aggravates left ventricular remodeling by disrupting the extracellular-signal-regulated kinase1/2 signaling pathway in rats after acute myocardial infarction[J]. J Cell Physiol, 2019,234(10):18653-18665.
[10].Taylor DS,Cheng X,Pawlowski JE,et al. Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin Ⅱ, endothelin-1,and thrombin[J]. Proc Natl Acad Sci U S A,1999,96(4):1633-1638.
[11].Thomas MP,Moscucci M,Smith DE,et al. Outcome of contemporary percutaneous coronary intervention in the elderly and the very elderly:insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium[J]. Clin Cardiol,2011,34(9):549-554.
[12].Borghi C,Omboni S,Reggiardo G,et al. Efficacy of zofenopril in combination with amlodipine in patients with acute myocardial infarction: a pooled individual patient data analysis of four randomized, double-blind, controlled, prospective studies[J]. Curr Med Res Opin,2018,34(10):1869-1874.
[13].Haig C,Carrick D,Carberry J,et al. Current smoking and prognosis after?acute ST-segment elevation myocardial?infarction:new pathophysiological insights[J]. JACC Cardiovasc Imaging,2019,12(6):993-1003.
[14].Wurm S,Zhang J,Guinea-Viniegra J,et al. Terminal epidermal differentiation is regulated by the interaction of Fra-2/AP-1 with Ezh2 and ERK1/2[J]. Genes Dev,2015,29(2):144-156.
[15].Zhang H,Xue G,Zhang W,et al. Akt and Erk1/2 activate the ornithine decarboxylase/polyamine system in cardioprotective ischemic preconditioning in rats:the role of mitochondrial permeability transition pores[J]. Mol Cell Biochem, 2014,390(1-2):133-142.
[16].Hernández-Reséndiz S,Roldán FJ,Correa F,et al. Postconditioning protects against reperfusion injury in hypertensive dilated cardiomyopathy by activating MEK/ERK1/2 signaling[J]. J Card Fail,2013,19(2):135-146.
[17].Tamareille S,Mateus V,Ghaboura N,et al. RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioning[J]. Basic Res Cardiol,2011,106(6):1329-1339.
[18].Cao Y,Xia DS,Qi SR,et al. Epiregulin can promote proliferation of stem cells from the dental apical papilla via MEK/Erk and JNK signalling pathways[J]. Cell Prolif, 2013,46(4):447-456.

相似文献/References:

[1]谷阳 史亚非 张刚 张东营 张清.急性ST段抬高型心肌梗死患者血浆中性粒细胞明胶酶相关脂质运载蛋白水平与梗死后心室重构的相关性研究[J].心血管病学进展,2019,(5):836.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.042]
 GU Yang,SHI Yafei,ZHANG Gang,et al.Neutrophil Gelatinase-associated Lipocalin is Associated with Cardiac Remodeling in Patients with ST-segment Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(1):836.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.042]
[2]赵鸿泽 刘剑雄.急性ST段抬高型心肌梗死介入手术时间窗与心室重塑的相关性研究[J].心血管病学进展,2020,(2):208.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.028]
 ZHAO Hongze,LIU Jianxiong.Correlation between the Onset Time and Ventricular Remodeling in Scute ST-segment Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(1):208.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.028]
[3]邓媛 李伟 熊信林 段宗刚.急性ST段抬高型心肌梗死救治时间节点对预后影响的研究进展[J].心血管病学进展,2021,(11):1024.[doi:10.16806/j.cnki.issn.1004-3934.2021.11.000]
 DENG Yuan,LI Wei,XIONG Xinlin,et al.Effect of Treatment Time Node on Prognosis of STEMI[J].Advances in Cardiovascular Diseases,2021,(1):1024.[doi:10.16806/j.cnki.issn.1004-3934.2021.11.000]
[4]刘丽芳 彭瑜 张钲.急性ST段抬高型心肌梗死患者再灌注后心肌内出血的研究进展[J].心血管病学进展,2022,(5):444.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.015]
 LIU Lifang,PENG Yu,ZHANG Zheng.Intracardial Hemorrhage After Reperfusion in Patients with Acute ST-Segment Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2022,(1):444.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.015]
[5]张兆元 马茜钰 张丹 彭石 张锦.C反应蛋白与高密度脂蛋白胆固醇比值、N末端脑钠肽前体与射血分数比值对STEMI患者PCI术后院内MACE的预测价值研究[J].心血管病学进展,2023,(2):186.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.020]
 ZHANG ZhaoyuanMA QianyuZHANG DanPENG ShiZHANG Jin.The Predictive Value of C-reactive Protein to High Density Lipoprotein Cholesterol Ratio and NT-proBNP to Ejection Fraction Ratio for Hospital MACE in Patients with STEMI After PCI[J].Advances in Cardiovascular Diseases,2023,(1):186.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.020]
[6]苏利芳 汪雁博 刘畅畅 姜云发.急性ST段抬高型心肌梗死后支架置入时机的研究进展[J].心血管病学进展,2024,(5):429.[doi:10.16806/j.cnki.issn.1004-3934.2024.05.011]
 SU Lifang,WANG Yanbo,LIU Changchang,et al.The Timing of Stent Implantation for Acute ST S egment Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2024,(1):429.[doi:10.16806/j.cnki.issn.1004-3934.2024.05.011]
[7]谭晓丽 范子胤 谢根源 刘向阳 欧阳繁.替奈普酶在急性ST段抬高型心肌梗死患者中研究的现状与进展[J].心血管病学进展,2024,(9):834.[doi:10.16806/j.cnki.issn.1004-3934.2024.09.015]
 TAN Xiaoli,FAN Ziyin,XIE Genyuan,et al.Current Status and Progress of Study of Tenecteplase in Patients with Acute ST S egment Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2024,(1):834.[doi:10.16806/j.cnki.issn.1004-3934.2024.09.015]

备注/Memo

备注/Memo:
基金项目:北京市卫计委首发专项(2018-2-7082)通讯作者:郭金成,E-mail:2322544273@qq.com
更新日期/Last Update: 2020-03-24